Treace Medical Concepts, Inc. Increase (Decrease) in Other Operating Assets and Liabilities, Net
Treace Medical Concepts, Inc. (TMCI) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of -$278.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-07
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was -$43.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was -$235.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was $58.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$36.00K, a 128.35% decline year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$35.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$97.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$40.00K.
- Treace Medical Concepts, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$278.00K 10-Q · filed 2026-08-07 | -$220.00K derived: sum of 3 quarters · filed 2026-08-07 | -$256.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$235.00K 10-Q · filed 2026-05-08 | -$177.00K derived: sum of 2 quarters · filed 2026-05-08 | -$213.00K derived: sum of 3 quarters · filed 2026-05-08 | -$213.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.00K derived: sum of 2 quarters · filed 2026-02-27 | $22.00K derived: sum of 3 quarters · filed 2026-08-07 | -$35.00K 10-K · filed 2026-02-27 | |
| 2025-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$36.00K derived: sum of 2 quarters · filed 2026-08-07 | -$93.00K 10-Q · filed 2025-11-06 | -$190.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$57.00K 10-Q · filed 2026-08-07 | -$154.00K derived: sum of 3 quarters · filed 2026-08-07 | -$27.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$57.00K 10-Q · filed 2026-05-08 | -$154.00K derived: sum of 2 quarters · filed 2026-05-08 | -$27.00K derived: sum of 3 quarters · filed 2026-05-08 | -$47.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $30.00K derived: sum of 2 quarters · filed 2026-02-27 | $10.00K derived: sum of 3 quarters · filed 2026-02-27 | -$97.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $107.00K derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$127.00K 10-Q · filed 2025-08-07 | -$127.00K derived: sum of 3 quarters · filed 2026-02-27 | -$129.00K derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | -$107.00K 10-Q · filed 2025-05-08 | -$107.00K derived: sum of 2 quarters · filed 2026-02-27 | -$109.00K derived: sum of 3 quarters · filed 2026-02-27 | -$122.00K derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.00K derived: sum of 2 quarters · filed 2026-02-27 | -$15.00K derived: sum of 3 quarters · filed 2026-02-27 | -$40.00K 10-K · filed 2026-02-27 | |
| 2023-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$15.00K derived: sum of 2 quarters · filed 2024-11-05 | -$40.00K 10-Q · filed 2024-11-05 | -$40.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$38.00K 10-Q · filed 2024-08-06 | -$38.00K derived: sum of 3 quarters · filed 2025-02-27 | -$38.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$25.00K 10-Q · filed 2024-05-07 | -$25.00K derived: sum of 2 quarters · filed 2025-02-27 | -$25.00K derived: sum of 3 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | ||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | $300.00K 10-K · filed 2023-03-08 | |||
| 2020-12-31 | $1.10M 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |